[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 24/31, 1999

Effect of Immediate-Release Glipizide on Hypoglycemic Vulnerability in Fasted, Elderly Patients With Type 2 Diabetes

Author Affiliations
 

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;281(12):1084-1085. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-12-jbk0324

To the Editor: We published a study demonstrating that the hypoglycemic effect of maximal doses of once-daily second-generation sulfonylureas is minimal when administered to elderly subjects with type 2 diabetes during a prolonged fast.1 However, the issue of whether immediate-release sulfonylureas have increased hypoglycemic potential during such a fast remains controversial. Because comparative studies have shown that fasting and postprandial serum insulin concentrations are increased following immediate-release glipizide administration compared with glipizide gastrointestinal therapeutic system (GITS) administration, we investigated whether the risk of hypoglycemia is increased in elderly patients with type 2 diabetes taking immediate-release glipizide compared with glipizide GITS during a prolonged fast.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×